Based on data from the Salinas Valley, California growing region, the model could complement existing produce safety assessments by helping regulators, researchers, and industry stakeholders identify locations that may warrant additional environmental investigation.
The agency cited the Delaney Clause and industry abandonment in its decisions to revoke the authorizations for specific uses of methylene chloride, ethylene dichloride, and trichloroethylene as color additives or in the production of color additives.
Proposed by Representative Nancy Mace (R-SC), the prohibition would apply to color additives subject to FDA certification and certified color additive lakes. Color additives exempt from FDA certification, including many naturally derived colors, would not be affected.
As FDA expands its oversight of food contaminants, manufacturers, retailers, and distributors must understand evolving regulatory expectations and take proactive steps to identify, monitor, and mitigate contamination risks.
“Under current regulations, FDA is generally not authorized to disclose supply chain information,” stated an opinion from the U.S. Attorney General’s Office of Legal Counsel. However, “FDA has statutory authority to amend its regulations to allow broader disclosure of supply chain information.”
FDA, CDC, and USDA-FSIS researchers analyzed foodborne illness surveillance data against targets set under the Healthy People initiative, finding worsening incidence of campylobacteriosis, listeriosis, and STEC infections, with no detectable change in salmonellosis incidence, while acknowledging the potential role of advanced surveillance methods.
The actions are part of FDA's Closer to Zero initiative, which aims to continually reduce dietary exposure to toxic heavy metals among babies and young children.
This episode covers the final findings from the U.S. Cyclospora outbreak, new USDA efforts to address Listeria, the new FDA Food Code, research on high-pressure processing for raw chicken, and emerging food safety concerns associated with plastic pollution.
FDA tested 195 samples from 2022–2025. No violations were identified among domestic samples, but 4.5 percent of imported samples showed evidence of economically motivated adulteration.